GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » Interest Expense

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Interest Expense : ¥-20 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Jiangsu Kanion Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jiangsu Kanion Pharmaceutical Co's interest expense for the three months ended in Mar. 2025 was ¥ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jiangsu Kanion Pharmaceutical Co's Operating Income for the three months ended in Mar. 2025 was ¥ 102 Mil. Jiangsu Kanion Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -3 Mil. Jiangsu Kanion Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2025 was 33.31. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jiangsu Kanion Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Jiangsu Kanion Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Kanion Pharmaceutical Co Interest Expense Chart

Jiangsu Kanion Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.47 -11.15 -1.91 -1.46 -22.30

Jiangsu Kanion Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.16 6.16 - -22.77 -3.05

Jiangsu Kanion Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Kanion Pharmaceutical Co  (SHSE:600557) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jiangsu Kanion Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2025 was ¥-3 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥102 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥0 Mil.

Jiangsu Kanion Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*101.593/-3.05
=33.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Jiangsu Kanion Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » Interest Expense
Comparable Companies
SZSE:300702 SZSE:000915 SZSE:000650 SHSE:601089 SZSE:002550 SHSE:600195 SZSE:000597 SHSE:688321 SZSE:000989 SHSE:688131 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001
Website
http://www.kanion.com
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
Executives
Pan Yu Director
Xu Dian Hong Director
Wang Chuan Lei Director
Yang Yong Chun Director
Liu Quan Director
Wang Zhen Zhong Director
Wu Yun Director
Gao Hai Xin Director
Xiao Wei Director
Wan Yan Huan senior management
Xia Yue Director
Yang Yin Director

Jiangsu Kanion Pharmaceutical Co Headlines

No Headlines